Slovenia Business Bridge discusses investment opportunities
Ljubljana, 24 September - The Slovenia Business Bridge conference discussed on Friday investment opportunities in Slovenia, where the need for partnership between the public and private was emphasised. Investments in human resources are also a must as they need to keep up with the constant development in technology and science.
Ljubljana
Infrastructure Minister Jernej Vrtovec speaks at a panel on infrastructure and energy of future as part of the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Investment director of Amber Fund Joseph Philipsz speaks at a panel on infrastructure and energy of future as part of the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Infrastructure Minister Jernej Vrtovec speaks at a panel on infrastructure and energy of future as part of the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
A panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Mark Pleško, CEO of Cosylab, takes part in a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Maja Ravnikar, director of the National Institute of Biology, addresses a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Jernej Zupančič, executive director of Cleangrad, takes part in a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Robert Ljoljo, CEO of pharma company Lek, addresses a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Robert Ljoljo, CEO of pharma company Lek, addresses a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Jernej Zupančič, executive director of Cleangrad, takes part in a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Borut Čeh, executive director of Labena, takes part in a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Mark Pleško, CEO of Cosylab, addresses a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Jernej Zupančič, executive director of Cleangrad, takes part in a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Maja Ravnikar, director of the National Institute of Biology, addresses a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Mark Pleško, CEO of Cosylab, addresses a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
A panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
A panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
A panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Jernej Zupančič, executive director of Cleangrad, takes part in a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
Ajša Vodnik, director general of AmCham Slovenija, addresses a panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
Ljubljana
A panel on biomedicine and biotechnology at the Slovenia Business Bridge conference.
Photo: Nebojša Tejić/STA
The rest of this news item is available to subscribers.
The news item consists of 3.042 characters (without spaces) or 555 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.